New Age Alpha Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Sell
4,784
-119
-2% -$54.9K 0.11% 247
2026
Q1
$2.35M Sell
4,903
-112
-2% -$57.3K 0.11% 272
2025
Q4
$2.82M Sell
5,015
-42
-0.8% -$23.8K 0.12% 259
2025
Q3
$2.6M Sell
5,057
-149
-3% -$65.1K 0.11% 255
2025
Q2
$1.63M Buy
5,206
+31
+0.6% +$9.31K 0.07% 340
2025
Q1
$1.58M Sell
5,175
-503
-9% -$169K 0.07% 355
2024
Q4
$1.89M Buy
+5,678
New +$1.93M 0.08% 334

Other funds holding MEDP

New Age Alpha Advisors's MEDP Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Medpace (MEDP) stake by 2.4% in Q2 2026, selling an estimated $54.9K and leaving 4,784 shares worth $2.53M. The position accounts for 0.11% of the portfolio, ranked #247.

New Age Alpha Advisors first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.82M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • New Age Alpha Advisors held 4,784 shares of Medpace worth $2.53M as of Q2 2026.
  • New Age Alpha Advisors sold 119 Medpace shares in Q2 2026, an estimated $54.9K.
  • Medpace made up 0.11% of New Age Alpha Advisors's portfolio in Q2 2026, its #247 holding.
  • New Age Alpha Advisors first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • New Age Alpha Advisors's Medpace position peaked at $2.82M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.